Monument Therapeutics collaborates with the University of Nottingham on pioneering schizophrenia study Monument Therapeutics collaborates with the University of Nottingham on pioneering schizophrenia study
Monument Therapeutics is delighted to announce the appointment of Dr Paula Moran to its Scientific Advisory Board Monument Therapeutics is delighted to announce the appointment of Dr Paula Moran to its Scientific Advisory Board
Monument Therapeutics is delighted to announce the appointment of Dr Julian Gilbert to its Board as a Non-Executive Director Monument Therapeutics is delighted to announce the appointment of Dr Julian Gilbert to its Board as a Non-Executive Director
Digital brain biomarker company Monument Therapeutics raises £2.6 million Digital brain biomarker company Monument Therapeutics raises £2.6 million
